DE69407292D1 - Verfahren zur herstellung von liposomen - Google Patents

Verfahren zur herstellung von liposomen

Info

Publication number
DE69407292D1
DE69407292D1 DE69407292T DE69407292T DE69407292D1 DE 69407292 D1 DE69407292 D1 DE 69407292D1 DE 69407292 T DE69407292 T DE 69407292T DE 69407292 T DE69407292 T DE 69407292T DE 69407292 D1 DE69407292 D1 DE 69407292D1
Authority
DE
Germany
Prior art keywords
producing liposome
liposome
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69407292T
Other languages
English (en)
Other versions
DE69407292T2 (de
Inventor
Chung Hsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DE69407292D1 publication Critical patent/DE69407292D1/de
Publication of DE69407292T2 publication Critical patent/DE69407292T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69407292T 1993-06-30 1994-06-29 Verfahren zur herstellung von liposomen Expired - Fee Related DE69407292T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8493393A 1993-06-30 1993-06-30
PCT/US1994/007327 WO1995001164A1 (en) 1993-06-30 1994-06-29 Method for preparing liposomes

Publications (2)

Publication Number Publication Date
DE69407292D1 true DE69407292D1 (de) 1998-01-22
DE69407292T2 DE69407292T2 (de) 1998-06-25

Family

ID=22188126

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69407292T Expired - Fee Related DE69407292T2 (de) 1993-06-30 1994-06-29 Verfahren zur herstellung von liposomen

Country Status (7)

Country Link
US (1) US5653996A (de)
EP (1) EP0706374B1 (de)
JP (1) JPH08512056A (de)
AU (1) AU689786B2 (de)
CA (1) CA2163860A1 (de)
DE (1) DE69407292T2 (de)
WO (1) WO1995001164A1 (de)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399746A (en) * 1994-02-07 1995-03-21 Witco Corporation Diquaternary bleach activators and compositions containing them
GB9503486D0 (en) * 1995-02-22 1995-04-12 Secr Defence Pharmaceuticals and assays using enzyme subunits
WO1996028247A1 (de) * 1995-03-15 1996-09-19 Inotech Ag Verkapselungsgerät
US5902604A (en) * 1995-06-06 1999-05-11 Board Of Regents, The University Of Texas System Submicron liposome suspensions obtained from preliposome lyophilizates
US5891465A (en) * 1996-05-14 1999-04-06 Biozone Laboratories, Inc. Delivery of biologically active material in a liposomal formulation for administration into the mouth
US6056973A (en) * 1996-10-11 2000-05-02 Sequus Pharmaceuticals, Inc. Therapeutic liposome composition and method of preparation
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
ATE554748T1 (de) * 1997-11-14 2012-05-15 Pacira Pharmaceuticals Inc Herstellung von multivesikulären liposomen
US6221425B1 (en) 1998-01-30 2001-04-24 Advanced Cardiovascular Systems, Inc. Lubricious hydrophilic coating for an intracorporeal medical device
US6372720B1 (en) * 1998-02-05 2002-04-16 Kenneth J. Longmuir Liposome fusion and delivery vehicle
DE19812195C2 (de) * 1998-03-19 2000-03-30 Uwe Storch Verfahren zur Herstellung eines gewebebildenden Implantats und seine Verwendung
US6855296B1 (en) 1998-11-13 2005-02-15 Optime Therapeutics, Inc. Method and apparatus for liposome production
IL143104A (en) * 1998-11-13 2005-09-25 Optime Therapeutics Inc Method and apparatus for liposome production
US20050196345A1 (en) * 1999-02-03 2005-09-08 Max-Delbruck-Centrum Fur Molekulare Medizin Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols
IT1306129B1 (it) * 1999-04-13 2001-05-30 Sigma Tau Ind Farmaceuti Esteri della l-carnitina o di alcanoil l-carnitine utilizzabili comelipidi cationici per l'immissione intracellulare di composti
CN1228041C (zh) * 1999-07-15 2005-11-23 英耐克斯药品股份有限公司 脂质包埋的治疗剂的制备方法
WO2001041738A2 (en) * 1999-12-10 2001-06-14 Celator Technologies Inc. Lipid carrier compositions with protected surface reactive functions
US7115297B2 (en) 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
JP4942273B2 (ja) 2000-03-21 2012-05-30 スティルマン、スザンヌ・ジャッフェ 有用かつ装飾的な要素と、支持部材と、放出システム及び方法とを備えたインフュージョンパケット
US8642051B2 (en) 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
US20030139356A1 (en) * 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
US20030105032A1 (en) * 2000-05-19 2003-06-05 Persing David H. Phophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
WO2002011695A2 (en) * 2000-08-07 2002-02-14 Inhale Therapeutic Systems, Inc. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
JP2004506530A (ja) * 2000-08-24 2004-03-04 ウィリアム・マーシュ・ライス・ユニバーシティ ポリマー巻き付け単層カーボンナノチューブ
WO2002032396A2 (en) * 2000-10-16 2002-04-25 Massachusetts Institute Of Technology Lipid-protein-sugar particles for delivery of nucleic acids
US20090191259A1 (en) * 2002-01-09 2009-07-30 Transave, Inc. Efficient liposomal encapsulation
US20030232075A1 (en) * 2002-05-06 2003-12-18 University Of Minnesota, A Minnesota Corporation Compositions for producing factor Xa
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP2338478B1 (de) * 2002-06-28 2014-07-23 Protiva Biotherapeutics Inc. Verfahren zur Herstellung von Liposomen
MXPA05008489A (es) * 2003-02-11 2005-10-18 Neopharm Inc Procedimiento de fabricacion para preparaciones liposomicas.
US20040166124A1 (en) * 2003-02-25 2004-08-26 Dunfield John Stephen Fluid-jet pens configured for making modulated release bioactive agents
US20050025822A1 (en) * 2003-05-30 2005-02-03 Wong Frances M.P. Method of pulmonary administration of an agent
EP1481665A1 (de) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Neue Lipidmischungen für synthetische Tenside
WO2005002546A1 (en) * 2003-06-27 2005-01-13 Smithkline Beecham Corporation Stabilized topotecan liposomal composition and methods
JP2007505043A (ja) * 2003-09-09 2007-03-08 ギリアード サイエンシーズ， インコーポレイテッド 処置用リポソーム
US20050232973A1 (en) * 2004-04-19 2005-10-20 Makarand Gore Systems and methods for preparation of pharmaceutical dosage using compositions containing aqueous vesicles
US20050244478A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Anti-excititoxic sustained release intraocular implants and related methods
MX2007006214A (es) * 2004-11-24 2008-04-16 Therakine Ltd Un implante para suministro de farmaco intraocular.
US8999944B2 (en) 2005-01-20 2015-04-07 University Of Rochester Thioredoxin interacting protein (TXNIP) as regulator of vascular function
AU2006274413B2 (en) * 2005-07-27 2013-01-10 Arbutus Biopharma Corporation Systems and methods for manufacturing liposomes
EP3015101B1 (de) 2005-10-03 2019-08-21 PINSKY, Mark A. Non-phospholipid liposomen enthaltend hyaluronsäure
KR101328851B1 (ko) * 2006-10-13 2013-11-14 키에시 파르마슈티시 엣스. 피. 에이. 개선된 특성을 가지는 재구성된 계면활성제
US9101671B2 (en) 2007-01-03 2015-08-11 Sanford-Burnham Medical Research Institute Methods and compositions related to clot binding compounds
US7985058B2 (en) * 2007-01-12 2011-07-26 Mark Gray Method and apparatus for making uniformly sized particles
US20100098752A1 (en) * 2007-01-18 2010-04-22 Pinsky Mark A Materials and Methods for Delivering Antioxidants into the Skin
US8071575B2 (en) * 2007-02-23 2011-12-06 University Of Louisville Research Foundation Methods and compounds for the targeted delivery of agents to bone for interaction therewith
EP2433496A1 (de) 2007-05-08 2012-03-28 Burnham Institute for Medical Research Nicht gewebespezifische Alkali-Phosphat-Hemmer und deren Verwendung zur Behandlung von Gefäßverkalkungen
WO2009023306A2 (en) 2007-05-09 2009-02-19 Burnham Institute For Medical Research Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens
CA2706317C (en) * 2007-12-03 2017-06-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Doc1 compositions and methods for treating cancer
ES2710498T3 (es) 2007-12-26 2019-04-25 Mark A Pinsky Formulaciones de colágeno para la mejora del cuidado de la piel
JP5917394B2 (ja) 2009-06-10 2016-05-11 ニューヨーク・ユニバーシティ 病理学的タウタンパク質の免疫学的標的化方法
CA2767392C (en) 2009-07-06 2017-03-14 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
US9907746B2 (en) 2009-07-06 2018-03-06 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
WO2011043980A1 (en) 2009-10-07 2011-04-14 Sanford Burnham Medical Research Institute Methods and compositions related to clot-binding lipid compounds
WO2011075725A1 (en) 2009-12-18 2011-06-23 Sanford-Burnham Medical Research Institute Methods and compositions related to clot-binding compounds
WO2011079304A1 (en) 2009-12-23 2011-06-30 Sanford-Burnham Medical Research Institute Methods and compositions related to annexin 1-binding compounds
US20110262347A1 (en) 2010-04-08 2011-10-27 The Salk Institute For Biological Studies Methods and compositions for enhanced delivery of compounds
EP3175844A1 (de) 2010-04-09 2017-06-07 Pacira Pharmaceuticals, Inc. Synthetischer membranvesikel mit hohem durchmesser
WO2012006367A2 (en) 2010-07-06 2012-01-12 Variation Biotechnologies, Inc. Compositions and methods for treating influenza
US20130344053A1 (en) 2010-12-28 2013-12-26 University Of Rochester Methods of Modifying Insulin Signaling Using Biliverdin Reductase (BVR) and BVR Derived Peptides
WO2012097346A1 (en) 2011-01-13 2012-07-19 Variation Biotechnologies, Inc. Compositions and methods for treating viral infections
EP2663288B1 (de) * 2011-01-13 2022-12-21 Variation Biotechnologies Inc. Verfahren zur vesikelherstellung und darin hergestellte formulierungen
WO2012118778A1 (en) 2011-02-28 2012-09-07 Sanford-Burnham Medical Research Institute Truncated car peptides and methods and compositions using truncated car peptides
WO2012122059A1 (en) 2011-03-04 2012-09-13 New York University Hydrogen bond surrogate macrocycles as modulators of ras
US10179801B2 (en) 2011-08-26 2019-01-15 Sanford-Burnham Medical Research Institute Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides
PL2753346T3 (pl) 2011-09-07 2020-10-19 Mount Sinai School Of Medicine Ceramidaza i różnicowanie komórek
US8877161B2 (en) 2011-10-19 2014-11-04 Georgia Regents Research Institute, Inc. GM1-like peptides and uses thereof
RS58562B1 (sr) * 2011-11-04 2019-05-31 Nitto Denko Corp Postupak za sterilnu proizvodnju čestica lipid-nukleinska kiselina
US9579338B2 (en) 2011-11-04 2017-02-28 Nitto Denko Corporation Method of producing lipid nanoparticles for drug delivery
WO2013104995A2 (en) 2012-01-12 2013-07-18 Variation Biotechnologies, Inc. Compositions and methods for treating viral infections
AU2013213345A1 (en) 2012-01-27 2014-08-28 Variation Biotechnologies, Inc. Methods and compositions for therapeutic agents
JP2015508779A (ja) 2012-02-16 2015-03-23 ニューヨーク・ユニバーシティ 低酸素状態で誘導可能な遺伝子発現の、オリゴオキソピペラジン非ペプチド性へリックス模倣体による制御
US9857371B2 (en) * 2012-05-08 2018-01-02 New York University Biomimetic emulsions
SI2854910T1 (sl) 2012-06-01 2020-09-30 Icahn School Of Medicine At Mount Sinai Nivoji ceramida pri zdravljenju in preprečevanju okužb
EP2861218A4 (de) * 2012-06-18 2015-12-16 Lipotec Lab Llc Liposomformulierungen
US9321749B1 (en) 2012-07-25 2016-04-26 Globavir Biosciences, Inc. Heterocyclic compounds and uses thereof
WO2014063155A1 (en) 2012-10-21 2014-04-24 University Of Rochester Thy1 (cd90) as a novel therapy to control adipose tissue accumulation
EP2912178B1 (de) 2012-10-25 2020-06-17 Whitehead Institute For Biomedical Research Superverstärker und verfahren zur verwendung davon
HUE046113T2 (hu) 2013-03-14 2020-02-28 Icahn School Med Mount Sinai Terápiás sav ceramidáz készítmények és azok elõállítási és felhasználási eljárásai
WO2015024022A2 (en) 2013-08-16 2015-02-19 University Of Rochester Designed peptides for tight junction barrier modulation
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
JP6373749B2 (ja) 2014-12-19 2018-08-15 富士フイルム株式会社 リポソームの製造方法及びリポソーム製造装置
JP6316182B2 (ja) 2014-12-19 2018-04-25 富士フイルム株式会社 リポソームの製造方法及びリポソーム製造装置
CA2977827C (en) 2015-03-19 2023-10-17 University Of Connecticut Systems and methods for continuous manufacturing of liposomal drug formulations
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
US11273151B2 (en) 2015-11-04 2022-03-15 Icahn School Of Medicine At Mount Sinai Methods of treating tumors and cancer, and identifying candidate subjects for such treatment
WO2017189730A1 (en) 2016-04-26 2017-11-02 Icahn School Of Medicine At Mount Sinai Treatment of hippo pathway mutant tumors and methods of identifying subjects as candidates for treatment
US11981752B2 (en) 2017-05-02 2024-05-14 Sanford Burnham Prebys Medical Discovery Institute Tumor associated monocyte/macrophage binding peptide and methods of use thereof
JP2021516757A (ja) 2018-03-27 2021-07-08 エンジーヴァント セラピューティックス ゲーエムベーハー ファーバー病マーカーおよびその使用
KR20190132281A (ko) * 2018-05-18 2019-11-27 한국과학기술원 폐 계면활성제 기반 항암제
CN110522917A (zh) * 2018-05-25 2019-12-03 成都瑞博克医药科技有限公司 一种甘露糖修饰的靶向纳米制剂
CA3103675A1 (en) 2018-06-21 2019-12-26 University Of Rochester Methods of treating or inhibiting onset of huntington's disease
WO2020152532A1 (en) 2019-01-23 2020-07-30 Enzyvant Therapeutics Gmbh Method of ameliorating a pro-inflammatory immunophenotype in farber disease subjects by repeated administration of a recombinant human acid ceramidase
CA3127985A1 (en) 2019-02-04 2020-08-13 University Of Tartu Bi-specific extracellular matrix binding peptides and methods of use thereof
US20230057355A1 (en) 2019-02-13 2023-02-23 University Of Rochester Gene networks that mediate remyelination of the human brain
EP3980054A1 (de) 2019-06-05 2022-04-13 University Of Rochester Neue konstruierte inhibitoren der bildung von dichten verbindungen
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
WO2023081633A1 (en) 2021-11-02 2023-05-11 University Of Rochester Tcf7l2 mediated remyelination in the brain
WO2023192998A1 (en) 2022-04-01 2023-10-05 Icahn School Of Medicine At Mount Sinai Treating orthopedic injury with a vector driving expression of acid ceramidase
WO2024163747A2 (en) 2023-02-02 2024-08-08 University Of Rochester Competitive replacement of glial cells

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4301968A (en) * 1976-11-08 1981-11-24 Sono-Tek Corporation Transducer assembly, ultrasonic atomizer and fuel burner
FI68721C (fi) * 1979-06-08 1985-10-10 Sono Tek Corp Med ultraljud fungerande braenslespridare
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
US4452747A (en) * 1982-03-22 1984-06-05 Klaus Gersonde Method of and arrangement for producing lipid vesicles
GB8322178D0 (en) * 1983-08-17 1983-09-21 Sterwin Ag Preparing aerosol compositions
JPS6058915A (ja) * 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
US4957735A (en) * 1984-06-12 1990-09-18 The University Of Tennessee Research Corporation Target-sensitive immunoliposomes- preparation and characterization
EP0172007B1 (de) * 1984-08-10 1991-05-22 Syntex (U.S.A.) Inc. Stabile Liposome mit wasserlöslichen Arzneimitteln
GB8423436D0 (en) * 1984-09-17 1984-10-24 Riker Laboratories Inc Preparation of liposomes
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4946787A (en) * 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4753788A (en) * 1985-01-31 1988-06-28 Vestar Research Inc. Method for preparing small vesicles using microemulsification
GB8502892D0 (en) * 1985-02-05 1985-03-06 Sterwin Ag Aerosol composition
US4830858A (en) * 1985-02-11 1989-05-16 E. R. Squibb & Sons, Inc. Spray-drying method for preparing liposomes and products produced thereby
US4921757A (en) * 1985-04-26 1990-05-01 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
WO1986006959A1 (en) * 1985-05-22 1986-12-04 Liposome Technology, Inc. Liposome inhalation method and system
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
US4776991A (en) * 1986-08-29 1988-10-11 The United States Of America As Represented By The Secretary Of The Navy Scaled-up production of liposome-encapsulated hemoglobin
US4781871A (en) * 1986-09-18 1988-11-01 Liposome Technology, Inc. High-concentration liposome processing method
JPH01501228A (ja) * 1986-09-18 1989-04-27 リポソーム　テクノロジー，インコーポレイテッド 高濃度リポソーム処理方法
IE63869B1 (en) * 1986-11-06 1995-06-14 Res Dev Foundation Aerosols containing liposomes and method for their preparation
CA1338736C (fr) * 1986-12-05 1996-11-26 Roger Baurain Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
EP0357773B1 (de) * 1987-02-27 1992-07-15 Terumo Kabushiki Kaisha Verfahren zur herstellung von liposomen
US4895452A (en) * 1988-03-03 1990-01-23 Micro-Pak, Inc. Method and apparatus for producing lipid vesicles
AU3073789A (en) * 1988-03-31 1989-10-05 Abbott Laboratories Drug delivery using pulmonary surfactant to facilitate absorption
IL90561A (en) * 1988-06-08 1993-08-18 Fountain Pharm Inc Method for making solvent dilution microcarriers
US5077057A (en) * 1989-04-05 1991-12-31 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
US5019400A (en) * 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
JPH0739339B2 (ja) * 1989-05-01 1995-05-01 アルカーメス コントロールド セラピューティクス，インコーポレイテッド 生物活性を有する分子の小粒子の製造方法
ZA902710B (en) * 1989-05-22 1991-12-24 Univ Georgia Res Found Enzyme luminescence assay
FR2657257B1 (fr) * 1990-01-19 1994-09-02 Rhone Poulenc Sante Procede de preparation de medicaments sous forme de perles.
WO1992003123A1 (en) * 1990-08-28 1992-03-05 Liposome Technology, Inc. Liposome alternative bilayer formulations

Also Published As

Publication number Publication date
EP0706374B1 (de) 1997-12-10
EP0706374A1 (de) 1996-04-17
CA2163860A1 (en) 1995-01-12
AU689786B2 (en) 1998-04-09
JPH08512056A (ja) 1996-12-17
US5653996A (en) 1997-08-05
WO1995001164A1 (en) 1995-01-12
DE69407292T2 (de) 1998-06-25
AU7215194A (en) 1995-01-24

Similar Documents

Publication Publication Date Title
DE69407292D1 (de) Verfahren zur herstellung von liposomen
ATE243211T1 (de) Verfahren zur herstellung von dihalogenazolopyrimidinen
DE59708146D1 (de) Verfahren zur herstellung von polyalkoholen
DE69618020D1 (de) Verfahren zur herstellung von hydrofluorethern
DE59604922D1 (de) Verfahren zur herstellung von polyalkoholen
DE69428124D1 (de) Verfahren zur herstellung von perhalofluorierten butanen
DE69519379D1 (de) Verfahren zur herstellung von trifluorethylene
DE69604277D1 (de) Verfahren zur herstellung von nootkaton
ATE194850T1 (de) Verfahren zur herstellung von peroxiperfluoropolyxyalkylene
DE59601604D1 (de) Verfahren zur herstellung von n-aryl- und n-hetarylhydroxylaminen
DE59406740D1 (de) Verfahren zur herstellung von polytetrahydrofuran
DE59705109D1 (de) Verfahren zur herstellung von arylcyanaten
DE59305905D1 (de) Verfahren zur herstellung von n-alkanoyl-polyhydroxyalkylaminen
DE69414253D1 (de) Verfahren zur herstellung von oximin
DE69510466D1 (de) Verfahren zur herstellung von n-phosphonomethylglyzin
DE69327650D1 (de) Verfahren zur herstellung von chlordioxid
DE69616322D1 (de) Verfahren zur herstellung von 3-isochromanonen
DE59401406D1 (de) Verfahren zur herstellung von naphtalocyaninen
DE69615836D1 (de) Verfahren zur herstellung von boroxyd
ATE198318T1 (de) Verfahren zur herstellung von n-acetonylbenzamide
DE59509620D1 (de) Verfahren zur herstellung von acyloinen
DE59704683D1 (de) Verfahren zur herstellung von 6-aminocapronitril
DE59404478D1 (de) Verfahren zur herstellung von polyvinylpyridin-n-oxiden
DE69514369D1 (de) Verfahren zur herstellung von pentafluorethan
DE69324697D1 (de) Verfahren zur herstellung von dinitrotoluol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee